Torrent Pharma Q3 consequence: Web revenue up 43% to ₹619 cr, dividend declared | Firm Outcomes

Torrent Prescription drugs on Friday reported a 43 per cent bounce in its consolidated internet revenue to ₹619 crore within the third quarter of the monetary 12 months 2025-26 (Q3FY26). Throughout the identical quarter final 12 months, the corporate recorded a revenue of ₹433 crore. On a sequential foundation, revenue elevated round 20 per cent from ₹515 crore.

The corporate’s income from operations from the quarter elevated 17.7 per cent year-on-year (Y-o-Y) to ₹3,251 crore from ₹2,762 crore in Q3FY25. Sequentially, the income was flat from ₹3,246 crore.